SappanolCAS# 111254-19-4 |
- Episappanol
Catalog No.:BCN7940
CAS No.:111254-18-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 111254-19-4 | SDF | Download SDF |
PubChem ID | 13846649 | Appearance | Powder |
Formula | C16H16O6 | M.Wt | 304.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3R,4S)-3-[(3,4-dihydroxyphenyl)methyl]-2,4-dihydrochromene-3,4,7-triol | ||
SMILES | C1C(C(C2=C(O1)C=C(C=C2)O)O)(CC3=CC(=C(C=C3)O)O)O | ||
Standard InChIKey | MPGFEHZDABUJFR-JKSUJKDBSA-N | ||
Standard InChI | InChI=1S/C16H16O6/c17-10-2-3-11-14(6-10)22-8-16(21,15(11)20)7-9-1-4-12(18)13(19)5-9/h1-6,15,17-21H,7-8H2/t15-,16+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Sappanol inhibits lipid peroxidation in a concentration-dependent manner, can significantly attenuated H2O2-induced retinal death, can be potential antioxidant treatment for retinal diseases. |
Targets | ROS |
Sappanol Dilution Calculator
Sappanol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2862 mL | 16.4312 mL | 32.8623 mL | 65.7246 mL | 82.1558 mL |
5 mM | 0.6572 mL | 3.2862 mL | 6.5725 mL | 13.1449 mL | 16.4312 mL |
10 mM | 0.3286 mL | 1.6431 mL | 3.2862 mL | 6.5725 mL | 8.2156 mL |
50 mM | 0.0657 mL | 0.3286 mL | 0.6572 mL | 1.3145 mL | 1.6431 mL |
100 mM | 0.0329 mL | 0.1643 mL | 0.3286 mL | 0.6572 mL | 0.8216 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Episappanol
Catalog No.:BCN7940
CAS No.:111254-18-3
- CGS 20625
Catalog No.:BCC7375
CAS No.:111205-55-1
- 7,3',4'-Trihydroxy-3-benzyl-2H-chromene
Catalog No.:BCN1621
CAS No.:1111897-60-9
- 1,2-O-Dilinoleoyl-3-O-beta-D-galactopyranosylracglycerol
Catalog No.:BCN6768
CAS No.:111187-15-6
- PF-04880594
Catalog No.:BCC3998
CAS No.:1111636-35-1
- NF 110
Catalog No.:BCC7404
CAS No.:111150-22-2
- 14-Hydroxy sprengerinin C
Catalog No.:BCN2777
CAS No.:1111088-89-1
- FERb 033
Catalog No.:BCC7701
CAS No.:1111084-78-6
- Dacomitinib (PF299804, PF299)
Catalog No.:BCC3683
CAS No.:1110813-31-4
- Fmoc-Ser(Trt)-OH
Catalog No.:BCC3546
CAS No.:111061-56-4
- Fmoc-D-Lys(Trt)-OH
Catalog No.:BCC2594
CAS No.:111061-54-2
- N-Benzoyl-2-hydroxy-2-phenylethylamine
Catalog No.:BCN1622
CAS No.:111059-46-2
- Lestaurtinib
Catalog No.:BCC2440
CAS No.:111358-88-4
- Zileuton
Catalog No.:BCC2515
CAS No.:111406-87-2
- Azadirachtin
Catalog No.:BCC8123
CAS No.:11141-17-6
- Pinocembrin diacetate
Catalog No.:BCN5997
CAS No.:111441-88-4
- Axinysone B
Catalog No.:BCN7713
CAS No.:1114491-60-9
- Naltrindole hydrochloride
Catalog No.:BCC6773
CAS No.:111469-81-9
- Amlodipine Besylate
Catalog No.:BCC4397
CAS No.:111470-99-6
- 25-Anhydroalisol F
Catalog No.:BCN3361
CAS No.:1114895-01-0
- Ac-DL-Met-OH
Catalog No.:BCC2999
CAS No.:1115-47-5
- H-Ala-OEt.HCl
Catalog No.:BCC2687
CAS No.:1115-59-9
- L-Cysteinesulfinic acid
Catalog No.:BCC6571
CAS No.:1115-65-7
- Metformin HCl
Catalog No.:BCC4799
CAS No.:1115-70-4
One-step isolation of sappanol and brazilin from Caesalpinia sappan and their effects on oxidative stress-induced retinal death.[Pubmed:25248564]
BMB Rep. 2015 May;48(5):289-94.
Caesalpinia sappan is a well-distributed plant that is cultivated in Southeast Asia, Africa, and the Americas. C. sappan has been used in Asian folk medicine and its extract has been shown to have pharmacological effects. Two homoisoflavonoids, Sappanol and brazilin, were isolated from C. sappan by using centrifugal partition chromatography (CPC), and tested for protective effects against retinal cell death. The isolated homoisoflavonoids produced approximately 20-fold inhibition of N-retinylidene-N-retinyl-ethanolamine (A2E) photooxidation in a dose-dependent manner. Of the 2 compounds, brazilin showed better inhibition (197.93 +/- 1.59 muM of IC50). Cell viability tests and PI/Hoechst 33342 double staining method indicated that compared to the negative control, Sappanol significantly attenuated H2O2-induced retinal death. The compounds significantly blunted the up-regulation of intracellular reactive oxygen species (ROS), and Sappanol inhibited lipid peroxidation in a concentration-dependent manner. Thus, both compounds represent potential antioxidant treatments for retinal diseases.